Analysis of the Biomechanical Impact of Lower Limb Length Inequality in PEDiatrics (ABILMI-PED)

April 14, 2026 updated by: Hospices Civils de Lyon

Biomechanical Analysis of the Impact of Lower Limb Length Discrepancy on Hip and Lumbar Spine Joints in Children

Lower limb length discrepancy (LLD) is a frequent condition in pediatric orthopedics. Even moderate discrepancies can induce pelvic obliquity and compensatory scoliosis, modifying the distribution of joint loads at the hips and lumbar spine. These biomechanical imbalances are suspected to contribute to early degenerative conditions such as osteoarthritis or chronic low back pain.

The aim of this study is to quantify the biomechanical impact of LLD in children aged 10 to 15 years, using a combination of low dose biplanar EOS imaging (EOS Imaging System) and synchronized ground reaction force (GRF) measurements from integrated force platforms. These data will be used in musculoskeletal models developed in collaboration with the Biomechanics and Impact Mechanics Laboratory (LBMC, Laboratoire de Biomécanique et Mécanique des Chocs), enabling the estimation of hip joint and lumbar intervertebral disc loads.

This is the first pediatric study integrating EOS imaging, force platforms, and personalized musculoskeletal modeling to explore the mechanical consequences of LLD. The findings are expected to improve clinical reasoning and guide early therapeutic strategies.

Study Overview

Detailed Description

Lower limb length discrepancy (LLD) is a frequent condition in pediatric orthopedics. Even moderate discrepancies can induce pelvic obliquity and compensatory scoliosis, modifying the distribution of joint loads at the hips and lumbar spine. These biomechanical imbalances are suspected to contribute to early degenerative conditions such as osteoarthritis or chronic low back pain.

The aim of this study is to quantify the biomechanical impact of LLD in children aged 10 to 15 years, using a combination of low dose biplanar EOS imaging (EOS Imaging System) and synchronized ground reaction force (GRF) measurements from integrated force platforms. These data will be used in musculoskeletal models developed in collaboration with the Biomechanics and Impact Mechanics Laboratory (LBMC, Laboratoire de Biomécanique et Mécanique des Chocs), enabling the estimation of hip joint and lumbar intervertebral disc loads.

A temporary orthopedic compensation (shoe lift) will also be tested to assess its immediate biomechanical effect. Participants will be evaluated at baseline (two EOS acquisitions: with and without compensation) and at 2 years (without compensation).

This is the first pediatric study integrating EOS imaging, force platforms, and personalized musculoskeletal modeling to explore the mechanical consequences of LLD. The findings are expected to improve clinical reasoning and guide early therapeutic strategies.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Bron, France, 69500
        • Recruiting
        • Hospices Civils de Lyon Service d'Orthopédie et de Traumatologie
        • Contact:
        • Principal Investigator:
          • Thierry HAUMONT, Pr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population will consist of approximately 100 pediatric patients (aged 10 to 15 years) presenting with an anatomical lower limb length discrepancy (LLD) greater than 5 mm, confirmed by clinical evaluation. Participants will be recruited consecutively during routine outpatient visits at the Pediatric Orthopedics Department of Hôpital Femme-Mère-Enfant (HFME), Hospices Civils de Lyon, Bron, France. This hospital is a tertiary referral center in pediatric orthopedics, receiving children from the Rhône-Alpes region and beyond.

All included patients will undergo EOS imaging as part of their standard clinical assessment for LLD, ensuring that the study is fully integrated within the regular care pathway. The cohort therefore represents a specialized clinical sample of children with LLD, rather than a general population or community-based sample.

Description

Inclusion Criteria:

  • Children aged 10-15 years
  • Anatomical LLD > 5 mm, clinically measured
  • EOS imaging indicated by the pediatric orthopedic surgeon in routine care
  • Ability to stand still for 30 seconds without assistance
  • Covered by social security
  • Parental consent and non-opposition obtained

Exclusion Criteria:

  • - Functional or postural LLD without true anatomical discrepancy
  • History of major pelvic or spinal surgery
  • Severe neurological or orthopedic condition preventing standing (e.g. cerebral palsy, progressive myopathy)
  • Fixed equinus deformity preventing plantar support
  • Major lower limb deformity (severe genu varum/valgum)
  • Contraindication or inability to undergo EOS imaging

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Children with lower limb length discrepancy (LLD)
Pediatric patients aged 10-15 years with an anatomical LLD > 5 mm, evaluated in the routine pediatric orthopedic care pathway.
Low-dose biplanar radiographs of the whole body in standing position (EOS Imaging System). At baseline, two EOS acquisitions will be performed in static standing position : one without compensation (natural position) and one with temporary orthopedic compensation (shoe lift under the shorter limb). At 24 months, one EOS acquisition will be performed without compensation. Each acquisition lasts a few seconds, with radiation exposure 5 to 10 times lower than conventional radiographs.
Ground reaction force (GRF) measurements obtained from a force platform integrated in the EOS cabin. The platform records weight distribution and center of pressure during static standing posture. Measurements are fully synchronized with EOS acquisitions, without additional time or discomfort for participants. At baseline, GRF measurements will be collected in two conditions (with and without orthopedic compensation). At 24 months, GRF measurements will be collected in the non-compensated condition.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Asymmetry of Hip Joint Contact Forces (%) in Static Standing
Time Frame: At baseline (Day 0, without compensation)
Hip joint contact force asymmetry index (%): calculated as AI (%) = 100 × (F_long - F_short) / [(F_long + F_short)/2], where F_long and F_short are side-specific resultant hip joint contact forces (estimated by musculoskeletal modeling from EOS imaging and ground reaction force data). Units: percent (%).Higher values indicate greater asymmetry.
At baseline (Day 0, without compensation)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thierry HAUMONT, MD, Hospices Civils de Lyon

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 7, 2026

Primary Completion (Estimated)

June 7, 2029

Study Completion (Estimated)

June 7, 2029

Study Registration Dates

First Submitted

November 19, 2025

First Submitted That Met QC Criteria

November 19, 2025

First Posted (Actual)

November 28, 2025

Study Record Updates

Last Update Posted (Actual)

April 17, 2026

Last Update Submitted That Met QC Criteria

April 14, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lower Limb Length Discrepancy (LLD) in Children

Clinical Trials on EOS Imaging System

Subscribe